People · Operator
Named in public records as an officer, director or promoter · active 2014–2014 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Integrated Diagnostics, Inc. | — | Biotechnology | Series B | $45.3M | $242.1M | 2014 |
Kenneth Fang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kenneth Fang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Arnold Oronsky | 1 | 10 |
| Michael Liang | 1 | 9 |
| Stephen Davis | 1 | 8 |
| David Barker | 1 | 7 |
| Leroy Hood | 1 | 5 |
| James Heath | 1 | 5 |
| John Bencich | 1 | 3 |
| Albert Luderer | 1 | 2 |
| Jay Moyes | 1 | 2 |
| Douglas Sanders | 1 | 2 |
| David Galas | 1 | 1 |
| James Garner | 1 | 1 |
| Greg Critchfield | 1 | 1 |
| Paul Kearney | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.